OBJECTIVE: To report disease transformation in 3 imatinib mesylate treated Philadelphia chromosome-positive chronic myelogenous leukemia (Ph(+)CML) patients who achieved cytogenetic response.
--
Posted by Rob to CML Newswire: Medical And Technical News On Chronic Myelogenous Leukemia
at 2/17/2006 11:13:19 PM
--~--~---------~--~----~------------~-------~--~----~
You received this message because you are subscribed to the Google Groups "CMLHope" group.
To post to this group, send email to CMLHope@googlegroups.com
To unsubscribe from this group, send email to [EMAIL PROTECTED]
For more options, visit this group at http://groups.google.com/group/CMLHope
-~----------~----~----~----~------~----~------~--~---
